{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:25:42Z","timestamp":1778149542623,"version":"3.51.4"},"reference-count":138,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.purol.2022.08.003","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T21:55:29Z","timestamp":1668549329000},"page":"1164-1194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["French AFU Cancer Committee Guidelines\u00a0\u2013\u00a0Update 2022\u20132024: Upper urinary tract urothelial cancer (UTUC)"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4345-3598","authenticated-orcid":false,"given":"Y.","family":"Neuzillet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Seisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Traxer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5526-077X","authenticated-orcid":false,"given":"Y.","family":"Allory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-2075","authenticated-orcid":false,"given":"F.","family":"Audenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-1739","authenticated-orcid":false,"given":"Y.","family":"Loriot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Prad\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roumigui\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Xylinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Masson-Lecomte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roupret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2022.08.003_bib0695","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.purol.2022.08.003_bib0700","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1007\/s00345-020-03576-3","article-title":"Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study","volume":"39","author":"Alm\u00e5s","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0705","first-page":"966","article-title":"\u00c9pid\u00e9miologie et facteurs de risque des tumeurs de la voie excr\u00e9trice urinaire sup\u00e9rieure\u00a0: revue de la litt\u00e9rature pour le rapport annuel de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"24","author":"Ouzzane","year":"2014","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0710","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0715","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1464-410X.2007.06841.x","article-title":"Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments","volume":"100","author":"Sanderson","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib0720","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.1998.16.3.1099","article-title":"Extravesical tumor relapse in patients with superficial bladder tumors","volume":"16","author":"Herr","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib0725","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.urolonc.2018.02.009","article-title":"Upper tract urothelial carcinoma following intravesical bacillus Calmette-Gu\u00e9rin therapy for nonmuscle-invasive bladder cancer: results from a multi-institutional retrospective study","volume":"36","author":"Nishiyama","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib0730","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","article-title":"A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma","volume":"67","author":"Seisen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0735","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.eururo.2012.06.029","article-title":"Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy","volume":"63","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0740","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)","volume":"342","author":"Nortier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2022.08.003_bib0745","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.nephro.2015.10.001","article-title":"[Aristolochic acid nephropathy (\u201cChinese herb nephropathy\u201d)]","volume":"11","author":"Nortier","year":"2015","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.purol.2022.08.003_bib0750","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7326\/0003-4819-158-6-201303190-00006","article-title":"The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review","volume":"158","author":"G\u00f6kmen","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.purol.2022.08.003_bib0755","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.2147\/CMAR.S178554","article-title":"Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients","volume":"10","author":"Xiong","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.purol.2022.08.003_bib0760","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fonc.2019.00157","article-title":"Gender is a significant prognostic factor for upper tract urothelial carcinoma: a large hospital-based cancer registry study in an endemic area","volume":"9","author":"Huang","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib0765","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1464-410X.2008.07565.x","article-title":"Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan","volume":"102","author":"Tan","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib0770","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/oemed-2013-101443","article-title":"Arsenic in drinking water and renal cancers in rural Bangladesh","volume":"70","author":"Mostafa","year":"2013","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.purol.2022.08.003_bib0775","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1470-2045(09)70041-5","article-title":"Management of extracolonic tumours in patients with Lynch syndrome","volume":"10","author":"Koornstra","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib0780","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.purol.2022.08.003_bib0785","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/PAS.0000000000001141","article-title":"Universal Lynch Syndrome screening should be performed in all upper tract urothelial carcinomas","volume":"42","author":"Ju","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.purol.2022.08.003_bib0790","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2017.08.002","article-title":"Universal point of care testing for lynch syndrome in patients with upper tract urothelial carcinoma","volume":"199","author":"Metcalfe","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0800","first-page":"954","article-title":"Anatomopathologie des tumeurs de la voie excr\u00e9trice urinaire sup\u00e9rieure\u00a0: \u00e9tat de l\u2019art pour le rapport annuel de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"24","author":"Varinot","year":"2014","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0805","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.juro.2012.04.009","article-title":"Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma","volume":"188","author":"Rink","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0810","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bju.14751","article-title":"Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy","volume":"124","author":"Zamboni","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib0815","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejrad.2017.10.021","article-title":"Upper tract urothelial cancer","volume":"98","author":"Froemming","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.purol.2022.08.003_bib0820","first-page":"987","article-title":"Imagerie des tumeurs des voies excr\u00e9trices sup\u00e9rieures\u00a0: \u00e9tat de l\u2019art pour le rapport scientifique annuel de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"24","author":"Puech","year":"2014","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0825","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ucl.2017.12.001","article-title":"Current staging strategies for muscle-invasive bladder cancer and upper tract urothelial cell carcinoma","volume":"45","author":"Mossanen","year":"2018","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.purol.2022.08.003_bib0830","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00330-019-06529-6","article-title":"Imaging protocols for CT urography: results of a consensus conference from the French Society of Genitourinary Imaging","volume":"30","author":"Renard-Penna","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.purol.2022.08.003_bib0835","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1464-410X.2007.06766.x","article-title":"Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour","volume":"99","author":"Cowan","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib0840","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejrad.2008.10.026","article-title":"Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: Systematic review and meta-analysis","volume":"73","author":"Chlapoutakis","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.purol.2022.08.003_bib0845","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/iju.13032","article-title":"Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma","volume":"23","author":"Jinzaki","year":"2016","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0850","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00345-019-02875-8","article-title":"Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis","volume":"38","author":"Janisch","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0855","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.juro.2009.12.031","article-title":"Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy","volume":"183","author":"Takahashi","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0860","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.urolonc.2015.12.002","article-title":"Trends in the utilization of imaging for upper tract urothelial carcinoma","volume":"34","author":"Mohapatra","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib0865","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1007\/s00261-019-02085-1","article-title":"Update on MR urography (MRU): technique and clinical applications","volume":"44","author":"Abreu-Gomez","year":"2019","journal-title":"Abdom Radiol N Y"},{"key":"10.1016\/j.purol.2022.08.003_bib0870","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00330-019-06530-z","article-title":"Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging","volume":"30","author":"Rouvi\u00e8re","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.purol.2022.08.003_bib0875","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/iju.14068","article-title":"Clinical staging of upper urinary tract urothelial carcinoma for T staging: review and pictorial essay","volume":"26","author":"Honda","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0880","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.05.0172","article-title":"Gadolinium-enhanced fat-suppressed T1-weighted imaging for staging ureteral carcinoma: correlation with histopathology","volume":"188","author":"Obuchi","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.purol.2022.08.003_bib0885","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2214\/AJR.10.6299","article-title":"Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI","volume":"197","author":"Akita","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.purol.2022.08.003_bib0890","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s00261-017-1116-5","article-title":"The value of adding diffusion-weighted images for tumor detection and preoperative staging in renal pelvic carcinoma for the reader's experience","volume":"42","author":"Yoshida","year":"2017","journal-title":"Abdom Radiol N Y"},{"key":"10.1016\/j.purol.2022.08.003_bib0895","first-page":"977","article-title":"Diagnostics clinique, ur\u00e9t\u00e9roscopique et photodynamique des tumeurs de la voie excr\u00e9trice urinaire sup\u00e9rieures\u00a0: \u00e9tat-de-l\u2019art pour le rapport scientifique annuel de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"24","author":"Nison","year":"2014","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0900","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0905","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib0910","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jasc.2021.12.003","article-title":"We\u2019ll always have Paris The Paris System for Reporting Urinary Cytology 2022","volume":"11","author":"Wojcik","year":"2022","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.purol.2022.08.003_bib0915","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.juro.2018.02.002","article-title":"Discordance between ureteroscopic biopsy and final pathology for upper tract urothelial carcinoma","volume":"199","author":"Margolin","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0920","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bju.13935","article-title":"Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis","volume":"120","author":"Marchioni","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib0925","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bju.14053","article-title":"Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis","volume":"121","author":"Guo","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib0930","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00345-019-02768-w","article-title":"Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage","volume":"38","author":"Baboudjian","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0935","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4111\/icu.2020.61.2.158","article-title":"Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer","volume":"61","author":"Chung","year":"2020","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0940","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00345-019-02675-0","article-title":"Which flexible ureteroscope is the best for upper tract urothelial carcinoma treatment?","volume":"37","author":"Keller","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0945","article-title":"Comparison of irrigation flows between different irrigation methods for flexible ureteroscopy: an in vitro study","author":"Grinholtz","year":"2022","journal-title":"Prog En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0950","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/end.2015.0387","article-title":"Can we provide low intrarenal pressures with good irrigation flow by decreasing the size of ureteral access sheaths?","volume":"30","author":"Sener","year":"2016","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2022.08.003_bib0955","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bju.14389","article-title":"Systematic review of ureteral access sheaths: facts and myths","volume":"122","author":"De Coninck","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib0960","doi-asserted-by":"crossref","first-page":"101617","DOI":"10.1016\/j.pdpdt.2019.101617","article-title":"5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence ureterorenoscopy for urinary upper tract urothelial carcinoma \u223cPreliminary prospective single centre trial\u223c","volume":"29","author":"Fukuhara","year":"2020","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.purol.2022.08.003_bib0965","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/end.2009.0593","article-title":"Narrow-band imaging digital flexible ureteroscopy in detection of upper urinary tract transitional-cell carcinoma: initial experience","volume":"25","author":"Traxer","year":"2011","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2022.08.003_bib0970","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1590\/s1677-5538.ibju.2016.0324","article-title":"Evaluation of the Spies TM modalities image quality","volume":"43","author":"Emiliani","year":"2017","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0975","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.euf.2017.05.008","article-title":"Correlation between confocal laser endomicroscopy (Cellvizio\u00ae) and histological grading of upper tract urothelial carcinoma: a step forward for a better selection of patients suitable for conservative management","volume":"4","author":"Breda","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.purol.2022.08.003_bib0980","first-page":"1000","article-title":"Facteurs pronostiques des tumeurs de la voie excr\u00e9trice sup\u00e9rieure et impact sur la survie\u00a0: une revue syst\u00e9matique pour le rapport annuel de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"24","author":"Colin","year":"2014","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0985","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2013.12.007","article-title":"A new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUCs) in a predefinitive treatment setting: low-risk versus high-risk UTUCs","volume":"66","author":"Roupr\u00eat","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib0990","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2022.08.003_bib0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.12.002","article-title":"Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma","volume":"37","author":"Petros","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1000","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.2988","article-title":"Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma","author":"Yoshida","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.purol.2022.08.003_bib1005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bju.12631","article-title":"Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and\/or locally advanced upper tract urothelial carcinoma without metastasis","volume":"114","author":"Seisen","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib1010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2016.07.036","article-title":"Prognostic factors of overall survival in upper urinary tract carcinoma: a systematic review and meta-analysis","volume":"100","author":"Petrelli","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.purol.2022.08.003_bib1015","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jso.25877","article-title":"Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract","volume":"121","author":"Rosiello","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.urolonc.2018.12.027","article-title":"Development and external validation of a nomogram predicting prognosis of upper tract urothelial carcinoma after radical nephroureterectomy","volume":"37","author":"Zeng","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1025","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/bjc.2012.64","article-title":"Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram","volume":"106","author":"Yates","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.purol.2022.08.003_bib1030","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/bjc.2013.462","article-title":"External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma","volume":"109","author":"Ku","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.purol.2022.08.003_bib1035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","article-title":"Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000318985","article-title":"Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society","volume":"85","author":"Heidenreich","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.purol.2022.08.003_bib1045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000381269","article-title":"Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography\/Computed tomography in upper tract urothelial carcinoma: impact on detection of metastases and patient management","volume":"96","author":"Tanaka","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.purol.2022.08.003_bib1050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejrad.2015.12.017","article-title":"FDG-PET\/CT as a post-treatment restaging tool in urothelial carcinoma: comparison with contrast-enhanced CT","volume":"85","author":"Kitajima","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.purol.2022.08.003_bib1055","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00259-015-3266-4","article-title":"Radiolabelled choline and FDG PET\/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma","volume":"43","author":"Zattoni","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2022.08.003_bib1060","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","article-title":"Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel","volume":"70","author":"Seisen","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1065","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1089\/end.2015.0044","article-title":"Immediate nephroureterectomy or after attempting conservative treatment, on elective indications, for upper urinary tract urothelial carcinoma: comparison of the pathology reports on a retrospective monocentric study","volume":"29","author":"Haddad","year":"2015","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2022.08.003_bib1070","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00345-015-1753-7","article-title":"Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings","volume":"34","author":"Villa","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12885-018-4118-y","article-title":"Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study","volume":"18","author":"Wen","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.purol.2022.08.003_bib1080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1089\/end.2019.0308","article-title":"Thulium-Holmium: YAG duo laser in conservative upper tract urothelial cancer treatment: 13 years experience from a tertiary national referral center","volume":"33","author":"Defidio","year":"2019","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2022.08.003_bib1085","first-page":"1011","article-title":"Traitement conservateur des tumeurs de la voie excr\u00e9trices sup\u00e9rieure\u00a0: revue de litt\u00e9rature syst\u00e9matique pour le rapport scientifique annuel de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"24","author":"Pignot","year":"2014","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1090","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00345-015-1753-7","article-title":"Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings","volume":"34","author":"Villa","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.juro.2017.07.088","article-title":"Which patients with upper tract urothelial carcinoma can be safely treated with flexible ureteroscopy with holmium:YAG laser photoablation? Long-term results from a high volume institution","volume":"199","author":"Villa","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bju.14697","article-title":"Segmental resection of distal ureter with termino-terminal ureteric anastomosis vs bladder cuff removal and ureteric re-implantation for upper tract urothelial carcinoma: results of a multicentre study","volume":"124","author":"Abrate","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib1105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4081\/aiua.2021.1.101","article-title":"Robot-assisted segmental ureterectomy with psoas hitch ureteral reimplantation: oncological, functional and perioperative outcomes of case series of a single centre","volume":"93","author":"Palagonia","year":"2021","journal-title":"Arch Ital Urol Androl Organo"},{"key":"10.1016\/j.purol.2022.08.003_bib1110","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1470-2045(20)30147-9","article-title":"Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial","volume":"21","author":"Kleinmann","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1115","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/JU.0000000000002350","article-title":"Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report","volume":"207","author":"Matin","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00345-012-0949-3","article-title":"Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes","volume":"31","author":"Audenet","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.urolonc.2019.02.004","article-title":"Endocavitary treatment for upper tract urothelial carcinoma: a meta-analysis of the current literature","volume":"37","author":"Foerster","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1130","first-page":"1021","article-title":"Traitement chirurgical des tumeurs de la voie excr\u00e9trice sup\u00e9rieure par n\u00e9phro-ur\u00e9t\u00e9rectomie totale\u00a0: \u00e9tat-de-l\u2019art pour le rapport annuel de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"24","author":"Neuzillet","year":"2014","journal-title":"Prog En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1135","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/jjco\/hyx085","article-title":"Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial","volume":"47","author":"Yamashita","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.euf.2017.10.003","article-title":"Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an European association of urology guidelines systematic review","volume":"5","author":"Peyronnet","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.purol.2022.08.003_bib1145","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.eururo.2011.12.026","article-title":"Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series","volume":"61","author":"Hanna","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1150","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00345-015-1712-3","article-title":"Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma","volume":"34","author":"Kim","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1155","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2009.06.013","article-title":"Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study","volume":"56","author":"Simone","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00345-019-03020-1","article-title":"Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases","volume":"38","author":"Veccia","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1165","doi-asserted-by":"crossref","first-page":"101607","DOI":"10.1016\/j.suronc.2021.101607","article-title":"Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a retrospective cohort study across ten years","volume":"38","author":"Zeuschner","year":"2021","journal-title":"Surg Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1170","doi-asserted-by":"crossref","DOI":"10.1089\/end.2021.0587","article-title":"Robotic vs laparoscopic nephroureterectomy for upper tract urothelial carcinoma: a multicenter propensity-score matched pair \u201ctetrafecta\u201d analysis (ROBUUST Collaborative Group)","author":"Veccia","year":"2022","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2022.08.003_bib1175","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2010.01.043","article-title":"Should urologists always perform a bladder cuff resection during nephroureterectomy, and which method should they use?","volume":"57","author":"Zlotta","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1180","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","article-title":"Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.23736\/S2724-6051.21.04247-8","article-title":"Single-stage Xi\u00ae robotic radical nephroureterectomy for upper tract urothelial carcinoma: surgical technique and outcomes","volume":"74","author":"Veccia","year":"2022","journal-title":"Minerva Urol Nephrol"},{"key":"10.1016\/j.purol.2022.08.003_bib1190","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00345-016-1764-z","article-title":"Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma","volume":"35","author":"Seisen","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1195","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.euf.2017.09.015","article-title":"Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the European association of urology guidelines panel on non-muscle-invasive bladder cancer","volume":"5","author":"Dominguez-Escrig","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.purol.2022.08.003_bib1200","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1442-2042.2012.03009.x","article-title":"Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract","volume":"19","author":"Kondo","year":"2012","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1205","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.juro.2015.06.077","article-title":"Patterns of lymphatic metastases in upper tract urothelial carcinoma and proposed dissection templates","volume":"194","author":"Matin","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2005.03.009","article-title":"Upper urinary tract cancer: location is correlated with prognosis","volume":"48","author":"van der Poel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1215","doi-asserted-by":"crossref","first-page":"E514","DOI":"10.1111\/j.1464-410X.2012.11199.x","article-title":"Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours","volume":"110","author":"Bin","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib1220","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0022-5347(17)47305-8","article-title":"The architecture of the musculature of the guinea-pig ureter as examined by scanning electron microscopy","volume":"134","author":"Tachibana","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1225","first-page":"1625","article-title":"A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma","volume":"42","author":"Fang","year":"2016","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1230","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.clgc.2019.10.015","article-title":"Segmental ureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies","volume":"18","author":"Veccia","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.purol.2022.08.003_bib1235","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","article-title":"Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy","volume":"112","author":"Xylinas","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.08.003_bib1240","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","article-title":"Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic therapy","volume":"79","author":"Leow","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1245","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/JU.0000000000000644","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1250","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clgc.2021.12.014","article-title":"Five and ten-year outcomes of neoadjuvant chemotherapy and surgery for high-risk upper tract urothelial carcinoma","volume":"20","author":"Adibi","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.purol.2022.08.003_bib1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.05.014","article-title":"A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02","volume":"40","author":"Necchi","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1260","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"O\u2019Brien","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1265","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","article-title":"Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial","volume":"31","author":"Ito","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1270","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","article-title":"Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma","volume":"35","author":"Seisen","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1275","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.purol.2022.08.003_bib1280","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(21)00004-8","article-title":"Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Bellmunt","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1285","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2022.08.003_bib1290","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1016\/j.prro.2021.02.005","article-title":"Predictors of locoregional recurrence and delineation of adjuvant radiation therapy fields for patients with upper tract urothelial carcinoma receiving nephroureterectomy","volume":"11","author":"Gao","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1295","first-page":"4051","article-title":"Effect of adjuvant radiotherapy on survival in patients with locoregional urothelial malignancies of the upper urinary tract","volume":"36","author":"Hahn","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.purol.2022.08.003_bib1300","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/jjco\/hys166","article-title":"A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"42","author":"Kitamura","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1305","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/iju.13010","article-title":"Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes","volume":"23","author":"Kobayashi","year":"2016","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1310","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.euf.2017.03.013","article-title":"Platinum-based neoadjuvant chemotherapy improves oncological outcomes in patients with locally advanced upper tract urothelial carcinoma","volume":"4","author":"Hosogoe","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.purol.2022.08.003_bib1315","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/JU.0000000000000172","article-title":"Optimizing the Sequence of chemotherapy for upper tract urothelial carcinoma with clinically positive regional lymph nodes","volume":"202","author":"Chakiryan","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1320","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.juro.2017.11.068","article-title":"Impact of primary tumor location on survival from the European organization for the research and treatment of cancer advanced urothelial cancer studies","volume":"199","author":"Moschini","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1325","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJMoa2002788","article-title":"Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma","volume":"383","author":"Powles","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2022.08.003_bib1330","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.purol.2022.08.003_bib1335","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S1470-2045(17)30616-2","article-title":"First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study","volume":"18","author":"Balar","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1340","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.eururo.2016.11.012","article-title":"Efficacy of systemic chemotherapy plus radical nephroureterectomy for metastatic upper tract urothelial carcinoma","volume":"71","author":"Seisen","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.euo.2019.06.014","article-title":"Efficacy of surgery in the primary tumor site for metastatic urothelial cancer: analysis of an international, multicenter, multidisciplinary database","volume":"3","author":"Moschini","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.purol.2022.08.003_bib1350","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"Pembrolizumab as second-line therapy for advanced urothelial carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2022.08.003_bib1355","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0140-6736(17)33297-X","article-title":"Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial","volume":"391","author":"Powles","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.purol.2022.08.003_bib1360","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1817323","article-title":"Erdafitinib in locally advanced or metastatic urothelial carcinoma","volume":"381","author":"Loriot","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2022.08.003_bib1365","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","article-title":"Enfortumab vedotin in previously treated advanced urothelial carcinoma","volume":"384","author":"Powles","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2022.08.003_bib1370","first-page":"616","article-title":"Surveillance des carcinomes uroth\u00e9liaux: revue du Comit\u00e9 de canc\u00e9rologie de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"25","author":"Colin","year":"2015","journal-title":"Prog En Urol J Assoc Fr Urol Soci\u00e9t\u00e9 Fr Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1375","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.eururo.2014.08.003","article-title":"Conditional survival after radical nephroureterectomy for upper tract carcinoma","volume":"67","author":"Ploussard","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.08.003_bib1380","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2022.04.003","article-title":"Oncologic surveillance after radical nephroureterectomy for high-risk upper tract urothelial carcinoma","author":"Martini","year":"2022","journal-title":"Eur Urol Oncol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708722003475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708722003475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:38:05Z","timestamp":1761115085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708722003475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":138,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1166708722003475"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2022.08.003","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French AFU Cancer Committee Guidelines\u00a0\u2013\u00a0Update 2022\u20132024: Upper urinary tract urothelial cancer (UTUC)","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2022.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}